Market at Close | Sensex, Nifty extend gains for 7th day; Midcaps decline amid weak market breadth – CNBC TV18

Market at Close | Sensex, Nifty extend gains for 7th day; Midcaps decline amid weak market breadth – CNBC TV18

[ad_1]

The benchmark indices continued their winning streak for the seventh consecutive session on Tuesday (March 25), with the Sensex gaining 33 points to close at 78,017 and the Nifty edging up 10 points to 23,669.

However, broader markets faced pressure as the NSE advance-decline ratio stood at 1:4. The Nifty Midcap Index fell 554 points to 51,970, while the Nifty Bank slipped 97 points to 51,608.

From the Sensex basket, UltraTech Cement Ltd, Bajaj Finserv Ltd, Infosys Ltd, Axis Bank Ltd, HCL Technologies Ltd and HDFC Bank Ltd were the major gainers. IndusInd Bank Ltd, Mahindra & Mahindra Ltd, Reliance Industries Ltd, Sun Pharmaceutical Industries Ltd, Tata Steel Ltd and ICICI Bank Ltd

were the biggest laggards.

Also Read: JSW Steel is now the most valued steel company in the world by market capitalisation

Cement stocks saw buying interest following a brokerage upgrade, with UltraTech emerging as the top gainer. IT stocks also advanced on a positive brokerage note, with Infosys, Persistent Systems, and Coforge leading the pack. In the banking space, HDFC Bank and Axis Bank were among the top gainers, helping Nifty Bank limit its losses.

Meanwhile, auto stocks lost ground, with M&M leading the decline after a brokerage downgrade. Among other notable gainers, Trent and Avenue Supermarts rose over 2% each on renewed buying interest.

On the losing side, midcap stocks such as Dixon Technologies, Zomato, MCX, Kalyan Jewellers, and CAMS were under pressure. Oil companies declined after the US announced a 25% tariff on countries importing oil from Venezuela.

Also Read: BMW Industries gains 10% on MoU with steel ministry for specialty steel under PLI scheme

JSW Energy fell over 3% after Ambit initiated coverage with a ‘Sell’ rating. Pharma stocks also faced selling pressure ahead of a possible US tariff announcement, with Dr Reddy’s Laboratories declining 3%.

[ad_2]

Source link

Back To Top
Translate »